We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Exercise and Diet Sharply Reduce Diabetes Risk

By HospiMedica staff writers
Posted on 15 Aug 2001
A major clinical trial comparing diet and exercise to treatment with metformin or placebo to prevent diabetes was ended a year early because the data demonstrated so clearly that diet and exercise cut the risk of type 2 diabetes by 58%. More...
Called the Diabetes Prevention Program, the trial was funded by the U.S. Institutes of Health (NIH; www.nih.gov) and other organizations. The U.S. prevalence of type 2 diabetes has tripled in the last 30 years, and much of the increase is due to the dramatic upsurge in obesity.

The 3,234 trial participants from 27 medical centers ranged in age from 25-85, with an average age of 51. All had impaired glucose tolerance and all were overweight. The participants were placed in one of three groups: a group taking placebo, a group taking metformin, and a group who exercised 150 minutes a week and lost 5-7% of their body weight by eating a low-fat diet. About 29% of the placebo group developed diabetes during the three-year follow-up, while about 22% of people who took metformin developed the disease. In contrast, only 14% of the people who exercised and lost weight developed diabetes.

"In view of the rapidly rising rates of obesity and diabetes in America, this good news couldn't come at a better time,” said Tommy G. Thompson, secretary of the U.S. Department of Health and Human Services. "So many of our health problems can be avoided through diet, exercise, and making sure we take care of ourselves.”




Related Links:
NIH

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.